XVIVO Update: Excellent organic growth and a negative currency surprise - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

XVIVO Update: Excellent organic growth and a negative currency surprise - Redeye

{newsItem.title}

XVIVO delivers impressive organic growth with reported sales below market expectations due to FX (currency) headwind. The increased disposable capacity contributed to 54% growth of Thoracic disposables (62% for the whole Thoracic business based on CER), the service offer is subject to improvements, and Abdominal disposables had a modest quarter at 13% organic growth. Our updated Base Case is SEK 565 (575) with a Bull Case of SEK 1,150 (1,100) and a Bear Case of SEK 165 (165).

Länk till analysen i sin helhet: https://www.redeye.se/research/1047503/xvivo-update-excellent-organic-growth-and-a-negative-currency-surprise?utm_source=finwire&utm_medium=RSS

Nyheter om Xvivo Perfusion

Läses av andra just nu

Om aktien Xvivo Perfusion

Senaste nytt